Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 320 | 5,570 | 70 | 2,800 | 610 |
| Marketable Securities | 12,320 | 9,090 | 7,830 | 7,000 | 10,060 |
| Other current assets | 260 | 220 | 570 | 280 | 590 |
| TOTAL | $12,900 | $14,880 | $8,470 | $10,080 | $11,260 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3,960 | 3,770 | 3,770 | 3,780 | 3,770 |
| TOTAL | $3,960 | $3,770 | $3,770 | $3,780 | $3,770 |
| Total Assets | $16,900 | $18,660 | $12,260 | $13,900 | $15,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,610 | 1,650 | 1,730 | 1,490 | 1,430 |
| TOTAL | $1,610 | $1,650 | $1,730 | $1,490 | $1,430 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,610 | $1,650 | $1,730 | $1,490 | $1,430 |
| Shareholders' Equity | |||||
| Common Shares | 140 | 140 | 130 | 130 | 130 |
| Retained earnings | -43,870 | -42,240 | -40,160 | -38,240 | -36,650 |
| Other shareholders' equity | 5,830 | 6,100 | 80 | 180 | 60 |
| TOTAL | $15,280 | $17,010 | $10,530 | $12,400 | $13,660 |
| Total Liabilities And Equity | $16,890 | $18,660 | $12,260 | $13,890 | $15,090 |